Dow Inc. is exploring the sale of its stake in Sadara Chemical, the roughly $20 billion joint venture it operates with Saudi Aramco, according to a Bloomberg report. The review comes as the U.S. chemicals giant works to streamline its portfolio during what has become a prolonged downturn in the global chemicals industry.
Sadara, based in Jubail, Saudi Arabia, is one of the world's largest integrated petrochemicals complexes, capable of producing more than 3 million metric tons of plastics and chemicals annually. But the venture has been under pressure as weak demand and oversupply have squeezed margins across the sector.
Why Dow is reshuffling
The potential Sadara sale is part of a broader cleanup at Dow. The company has been reassessing its non-core assets and, after launching a strategic review of some of its European operations in 2024, cut 13% of its workforce in January to boost profitability. These steps reflect a company trying to focus on higher-return businesses and reduce exposure to cyclical markets that have been slow to recover.
Chemicals makers worldwide have been grappling with a demand slump that began in 2022, as high interest rates, weak construction and manufacturing activity, and a slowdown in China have weighed on orders for plastics, coatings, and industrial materials. Many producers have responded by cutting costs, closing plants, or selling assets to shore up balance sheets.
What a sale could mean
If Dow proceeds with a sale, it would mark a significant exit from one of its largest joint ventures. Sadara was launched in 2011 as a partnership between Dow and Saudi Aramco to build a massive petrochemicals facility in Jubail, with the aim of diversifying Saudi Arabia's economy beyond oil. The venture has been a flagship project for both companies, but its financial performance has been challenged by the same industry headwinds affecting the rest of the sector.
For Dow, selling its stake could free up capital and reduce exposure to a volatile business line. The company has not confirmed the review, and Bloomberg noted that no final decision has been made. A sale would likely attract interest from other petrochemicals players or sovereign wealth funds, given the scale of the asset and its strategic location in the Middle East.
What it means for investors
For everyday investors, the news is a signal that Dow is serious about improving its financial health. Divesting a large, capital-intensive joint venture could help the company pay down debt, return cash to shareholders, or invest in more promising areas like specialty materials or packaging.
However, the chemicals downturn is not over, and any sale would take time to complete. Investors should watch for official announcements from Dow, as well as updates on its broader portfolio review. The company's ability to execute asset sales at attractive prices will be a key factor in how quickly it can recover from the current slump.
In the meantime, the news adds to a growing list of corporate divestitures and strategic reviews across the chemicals industry, as companies adapt to a slower-growth environment. For those holding Dow stock, the potential sale is a reminder that management is actively trying to reshape the business—but the benefits may take quarters to show up in the bottom line.
